Eli Lilly Chairman & CEO John Lechleiter discusses the productivity in its labs to find new medicines, and how the Affordable Care Act is impacting his business.
Lars Rebien Sørensen, CEO of Novo Nordisk, said demand in the U.S. and China had supported the company's strong earnings.
Gilles Andrier, CEO of Givaudan, says the company is present in many emerging markets across the globe and those markets are a 'huge pillar of growth' for the company.
Severin Schwan, CEO of Roche, says there is a low penetration of the company's medicines in emerging markets creating big growth potential.
Ivan Menezes, CEO of Diageo, says the company has "weathered" the emerging markets amid a slowdown in sales in several countries.
JJ Burns, JJ Burns & Company president & chief investment officer, and Bob Gelfond, MQS Management CEO, discuss where they will be investing in the wake of the Fed's direction to trim its bond purchasing program.
Patrick Doyle, Domino's Pizza president & CEO, discusses how Domino's is preparing for Super Bowl Sunday and weighs in on President Obama's views on minimum wage and job growth in America.
Sally Smith, President and CEO of Buffalo Wild Wings, explains how her company profits from every minute of the Super Bowl; reveals where her company plans to expand, and weighs in on growing competition with McDonald's.
Thomas Fanning, chairman, president & CEO of Southern Company, breaks down his company's fourth quarter numbers and weighs in on how this winter's extremely cold weather is impacting the energy industry.
Deutsche Bank's co-CEOs Anshu Jain, says the company's 2015 targets are "highly achievable" as the "legacy issues" and restructuring are being settled.
Andrew Liveris, President, Chairman & CEO of Dow Chemical, breaks down the chemical company's fourth quarter results and shares his thoughts on Dan Loeb's call to spin-off its petrochemical business.
Christian Clausen, CEO of Nordea, says he agrees with the Nordic regulators and believes it is important to hold a lot of capital in the current environment.
Joe Jimenez, CEO of Novartis, confirms the company's 2014 outlook, saying sales growth will be in the mid-single digits in the "worst case scenario" that there is generic competition to its blood pressure pill Diovan "relatively soon".
Breaking down today's market action and what the investment community is looking for the President to say during his State of the Union address, with Terry Dolan, Benjamin & Jerold Brokerage CEO.
Amid disappointing economic data across the board, CNBC's Jeff Cox and Peter Schiff, Euro Pacific Capital CEO, discuss if the Fed will reverse its course on tapering.
CNBC's Bob Pisani speaks with Matt Tucker, head of fixed income at iShares, about the Treasury's auction of floating-rate notes and what to do with bond funds.
First defense nasal screens are dust covers for the nose that filter out allergens. Joseph K. Moore, president and CEO of First Defense Nasal Screens appears on CNBC's "Power Lunch" to discuss how his business has expanded since appearing on "Shark Tank."
Discussing problems in emerging markets lately, and where to invest, with Kim Arthur, Main Management CEO; Mike Vogelzang, Boston Advisors president and CIO; and CNBC's Bob Pisani.
CNBC talks with Squarespace founder and CEO Anthony Casalena about the company's first Super Bowl commercial, as well as competition with GoDaddy.
GoDaddy is known for its risqué Super Bowl ads. CEO Blake Irving discusses the different approach the Web hosting company is taking this year.